Dow Jones

40 211,72

0,53%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ALTH

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
11/02/2008	14h00	Business Wire	Allos Therapeutics to Report 2007 Results on February 27, 2008	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/02/2008	20h07	Edgar (US Regulatory)	Allos Therapeutics Inc - Statement of Ownership (SC 13G)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/02/2008	21h23	Edgar (US Regulatory)	Allos Therapeutics Inc - Initial Statement of Beneficial Ownership (3)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/01/2008	14h00	PR Newswire (US)	Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
28/01/2008	14h00	PR Newswire (US)	Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
17/01/2008	23h00	Edgar (US Regulatory)	Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/01/2008	22h47	Edgar (US Regulatory)	Allos Therapeutics Inc - Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/01/2008	14h00	PR Newswire (US)	Allos Therapeutics Initiates Phase 2b Study of PDX in Patients With Non-small Cell Lung Cancer	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
27/12/2007	14h00	PR Newswire (US)	Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Periph	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
11/12/2007	14h00	PR Newswire (US)	Allos Therapeutics to Present at the 2008 JPMorgan Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/12/2007	14h00	PR Newswire (US)	Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/11/2007	14h00	PR Newswire (US)	Allos Therapeutics to Present at the 2007 BMO Capital Markets Focus on Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/11/2007	14h00	PR Newswire (US)	Allos Therapeutics to Present at the 2007 Lazard Capital Markets Healthcare Investor Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
12/11/2007	22h00	PR Newswire (US)	Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/11/2007	22h00	PR Newswire (US)	Allos Therapeutics to Present at the 2007 JMP Securities Healthcare Focus Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/11/2007	20h02	Edgar (US Regulatory)	Allos Therapeutics Inc - Quarterly Report (10-Q)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/11/2007	13h30	PR Newswire (US)	Allos Therapeutics Reports Third Quarter 2007 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
31/10/2007	13h00	PR Newswire (US)	Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
25/10/2007	22h01	PR Newswire (US)	Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
16/10/2007	13h55	PR Newswire (US)	Allos Therapeutics to Report 2007 Third Quarter Financial Results on November 5, 2007	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
26/09/2007	16h43	Edgar (US Regulatory)	Allos Therapeutics Inc (Other) (SC 13G)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/09/2007	21h35	Edgar (US Regulatory)	Allos Therapeutics Inc (Other) (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/09/2007	13h30	PR Newswire (US)	Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
13/09/2007	14h00	PR Newswire (US)	Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/09/2007	14h00	PR Newswire (US)	Allos Therapeutics to Present at the Bear Stearns 20th Annual Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
15/08/2007	14h00	PR Newswire (US)	Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/08/2007	15h00	PR Newswire (US)	Allos Therapeutics Reports Second Quarter 2007 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
18/07/2007	14h00	PR Newswire (US)	Allos Therapeutics to Report 2007 Second Quarter Financial Results on August 7, 2007	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
25/06/2007	15h30	PR Newswire (US)	Allos Therapeutics Selected to Join Russel 3000 Index	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
19/06/2007	12h30	PR Newswire (US)	Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)